\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t
Ipsen has a long and proud history of bringing innovative treatments to patients around the world. With its clear strategy, deep expertise, global presence, highly-committed teams and strong sense of purpose, Ipsen will continue to make a profound difference, now and for future generations.<\/p>\n\t\t\t\t\t\t\t\t\t\t<\/p>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t
\n\n\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tMarc de Garidel\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\tChairperson of the Board of Directors, since July 2016\t\t\t\t\t\t\t\t\t\t\t\t<\/p> \n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t<\/div>\n<\/section>\n\n\n\n\n
\n
\n \n
\n
Directors<\/h2>\n
<\/p>\n \n
\n
\n \n
\n
\n
\n\n \n
Antoine Flochel<\/p>\n \n\n \n
Vice-Chairperson <\/p>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n\n \n
Highrock S.\u00e0r.l.<\/p>\n \n\n \n
represented by Anne Beaufour 4<\/sup><\/p>\n <\/div>\n <\/div>\n <\/div>\n \n
\n
\n\n \n
Henri Beaufour<\/p>\n \n\n \n
Director <\/p>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n\n \n
Beech Tree S.A<\/p>\n \n\n \n
represented by Philippe Bonhomme 2;4<\/sup><\/p>\n <\/div>\n <\/div>\n <\/div>\n \n
\n
\n\n \n
Naomi Binoche<\/p>\n \n\n \n
Director 3<\/sup><\/p>\n <\/div>\n <\/div>\n <\/div>\n \n
\n
\n\n \n
Laetitia Ducroquet<\/p>\n \n\n \n
Director 3<\/sup><\/p>\n <\/div>\n <\/div>\n <\/div>\n \n
\n
\n\n \n
Margaret Liu<\/p>\n \n\n \n
Director 1<\/sup><\/p>\n <\/div>\n <\/div>\n <\/div>\n \n
\n
\n\n \n
David Loew<\/p>\n \n\n \n
Director 5<\/sup><\/p>\n <\/div>\n <\/div>\n <\/div>\n \n
\n
\n\n \n
Mich\u00e8le Ollier<\/p>\n \n\n \n
Director <\/p>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n\n \n
Pascal Touchon <\/p>\n \n\n \n
Director 1;6<\/sup><\/p>\n <\/div>\n <\/div>\n <\/div>\n \n
\n
\n\n \n
Piet Wigerinck<\/p>\n \n\n \n
Director 1<\/sup><\/p>\n <\/div>\n <\/div>\n <\/div>\n \n
\n
\n\n \n
Karen Witts<\/p>\n \n\n \n
Director 1<\/sup><\/p>\n <\/div>\n <\/div>\n <\/div>\n \n
\n
\n\n \n
Carol Xueref<\/p>\n \n\n \n
Director 2<\/sup><\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n<\/div> <\/section>\n <\/div>\n\n\n\n\n\n\n \n \n
\n
\n
<\/i>\n <\/div>\n \n
<\/p>\n
<\/p>\n
1<\/sup> Independent Directors <\/em><\/p>\n2<\/sup> Directors renewed at the Shareholders\u2019 Meeting of 28 May 2024<\/em><\/p>\n3<\/sup> Directors representing the employees <\/em><\/p>\n4<\/sup> Company governed by Luxembourg law <\/em><\/p>\n5<\/sup> CEO as of 1st<\/sup> July 2020 <\/em><\/p>\n6<\/sup> Cooptation ratified at the Shareholders\u2019 Meeting of 28 May 2024<\/em><\/p>\n<\/div>\n <\/div>\n <\/div>\n \n <\/div>\n <\/section>\n\n\n\n\n \n \n \n
\n \n
\n
\n
<\/h3>\n
<\/p>\n <\/div>\n <\/div>\n\n